IFNG and neoplasm: Indeed, when CAMA-1 and MDA-MB-231 were pretreated with an inducer of immunoproteasomes-IFN-γ, they could then be recognized by SATB1565–574 peptide-specific T cells (Figure 4B), suggesting that IFN-γ may enhance induction of immunoproteasomes, thus leading to the correct presentation of SATB1565–574 to the tumor cell surface for T cell scrutiny.